Trintellix Does NOT Have a Short Half-Life
No, Trintellix (vortioxetine) has a long half-life of approximately 66 hours (about 2.75 days), which is considerably longer than most other antidepressants. 11
Pharmacokinetic Profile
Vortioxetine's extended elimination half-life has several important clinical implications:
- Mean terminal half-life: ~66 hours (approximately 2.75 days) 1123
- Time to steady-state: approximately 2 weeks of daily dosing 11
- Peak plasma concentration (Tmax): 7-11 hours after oral administration 11
- Linear pharmacokinetics across the therapeutic dose range (5-20 mg) 1
Clinical Significance of the Long Half-Life
Dosing Convenience
The long half-life permits once-daily dosing without concern for missed doses causing immediate symptom recurrence 1. This contrasts sharply with shorter half-life SSRIs like paroxetine (which has discontinuation syndrome risk) 45.
Washout Period Considerations
The extended half-life requires careful attention when switching medications:
- Standard patients: Allow adequate washout time when transitioning to MAOIs to avoid serotonin syndrome 1
- Obese patients require even longer washout periods - the half-life extends to approximately 3.26 days in obese individuals (vs. 2.21 days in normal-weight controls), with up to 89% of variability explained by obesity indicators 6
Accumulation Profile
Due to the long half-life, vortioxetine accumulates extensively over repeated dosing, with an accumulation ratio of approximately 4.5-5.2 after 29 days of daily administration 6. This means steady-state concentrations are substantially higher than single-dose levels.
Comparative Context
To put this in perspective relative to other antidepressants mentioned in the evidence:
- Shorter half-life SSRIs: Sertraline, paroxetine, citalopram typically require 1-2 week intervals for dose adjustments 4
- Fluoxetine: Has an even longer half-life than vortioxetine (requires 3-4 week intervals) 4
- Vortioxetine at 66 hours: Falls in the "long half-life" category, requiring approximately 2 weeks to reach steady state 1
Practical Implications
The long half-life means:
- Missed doses are less clinically significant than with shorter-acting agents
- Discontinuation syndrome risk is lower compared to short half-life SSRIs like paroxetine 4
- Drug interaction considerations persist longer after discontinuation
- Dose adjustments should be made cautiously, waiting at least 1-2 weeks between changes to assess full effect 1